Activities of curcumin-related compounds in two cell lines persistently infected with different prion strains
Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells inf...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1866; no. 4; p. 130094 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains.
Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds.
In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers.
Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively.
The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.
[Display omitted]
•Two cells infected with different prion strains were treated with several compounds.•In one of the cells, the level of abnormal prion protein was reduced.•In the other cells, cross-linked dimer of abnormal prion protein was formed.•The different activities were explained with the characteristics of the compounds.•Preferable parameters for the respective activities of compounds were obtained. |
---|---|
AbstractList | Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSᶜ). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSᶜ level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSᶜ was not observed; instead, two other compounds promoted the formation of covalently linked PrPSᶜ dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSᶜ level in the ScN2a cells and the dimer formation of PrPSᶜ in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities. Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities. [Display omitted] •Two cells infected with different prion strains were treated with several compounds.•In one of the cells, the level of abnormal prion protein was reduced.•In the other cells, cross-linked dimer of abnormal prion protein was formed.•The different activities were explained with the characteristics of the compounds.•Preferable parameters for the respective activities of compounds were obtained. Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrP ). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrP level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrP was not observed; instead, two other compounds promoted the formation of covalently linked PrP dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrP level in the ScN2a cells and the dimer formation of PrP in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities. Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains.BACKGROUNDCultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains.Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds.METHODSCurcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds.In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers.RESULTSIn ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers.Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively.CONCLUSIONSChemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively.The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.GENERAL SIGNIFICANCEThe extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities. |
ArticleNumber | 130094 |
Author | Tsuchida, Rikiya Teruya, Kenta Watanabe-Matsui, Miki Watanabe, Yuki Konno, Hiroyuki Iwabuchi, Sara Doh-ura, Katsumi |
Author_xml | – sequence: 1 givenname: Kenta surname: Teruya fullname: Teruya, Kenta email: kenta.teruya.d4@tohoku.ac.jp organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan – sequence: 2 givenname: Sara surname: Iwabuchi fullname: Iwabuchi, Sara organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan – sequence: 3 givenname: Yuki surname: Watanabe fullname: Watanabe, Yuki organization: Graduate School of Science and Engineering, Yamagata University, Yonezawa 992-8510, Japan – sequence: 4 givenname: Rikiya surname: Tsuchida fullname: Tsuchida, Rikiya organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan – sequence: 5 givenname: Miki surname: Watanabe-Matsui fullname: Watanabe-Matsui, Miki organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan – sequence: 6 givenname: Hiroyuki surname: Konno fullname: Konno, Hiroyuki organization: Graduate School of Science and Engineering, Yamagata University, Yonezawa 992-8510, Japan – sequence: 7 givenname: Katsumi surname: Doh-ura fullname: Doh-ura, Katsumi organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35065183$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc1u3SAQhVGUKLlJ-wZVxbIb3wIGbLqoFEX9kyJl066RDUPLlQ23gBPl7YPltIsu2s4GjeY7o-GcS3QaYgCEXlGyp4TKt4f9OA7fIewZYWxPW0IUP0E72nes6QmRp2hHWsIbTqW4QJc5H0gtocQ5umgFkYL27Q7N16b4e188ZBwdNksyy-xDk2AaClhs4nyMS7AZ-4DLQ8QGpglPPlT-CCn7XCCU6bGOHZhV8eDLD2y9c5DqBB-TjwHnkgYf8gt05oYpw8vn9wp9-_jh683n5vbu05eb69vGtEqURinrRiqAUas6BnYcuJDOWs4tGaVRpva9AiE7oTqq2OjG1gqiRN8paixvr9Cbbe8xxZ8L5KJnn9fLhwBxyZrJVgrRCd79B8oY61QvRUVfP6PLOIPV9WvzkB71LzcrwDfApJhzAvcboUSvoemD3kLTa2h6C63K3v0hM74Mpfq2ujb9S_x-E0P1895D0tl4CAasTzUQbaP_-4InxQe1kA |
CitedBy_id | crossref_primary_10_1096_fj_202400614R crossref_primary_10_3987_REV_22_999 crossref_primary_10_1002_ptr_8119 |
Cites_doi | 10.1073/pnas.0710054104 10.1371/journal.pone.0146021 10.1016/S0882-4010(05)80008-7 10.1038/nmeth.2089 10.1108/EBR-10-2013-0128 10.1002/bip.21022 10.1128/JVI.77.9.5499-5502.2003 10.1128/JVI.74.9.4377-4386.2000 10.1074/jbc.M113.531335 10.1007/s10930-010-9278-9 10.1186/s13024-016-0074-7 10.1007/s00705-008-0177-8 10.1074/jbc.274.25.17981 10.1038/s41598-018-25966-9 10.1523/JNEUROSCI.0547-11.2011 10.1073/pnas.65.1.129 10.1021/jm9601617 10.1016/S1056-8719(02)00166-1 10.1016/j.febslet.2015.05.039 10.1128/JVI.74.1.320-325.2000 10.1016/j.bmcl.2013.11.039 10.1371/journal.pone.0137958 10.1016/j.bbagen.2018.11.008 10.1016/j.bmcl.2014.10.076 10.1016/0092-8674(84)90533-6 10.1021/acs.jmedchem.5b00104 10.1021/bi2003907 10.1128/JVI.01563-07 10.1126/science.1183218 10.1016/j.bbrc.2011.01.030 10.1038/embor.2011.192 10.3390/foods6100092 10.1016/j.bbrc.2015.03.139 10.1016/j.bmcl.2019.06.052 10.1016/0092-8674(87)90150-4 10.1016/j.xphs.2019.03.025 10.3390/cells9020349 10.1016/j.jom.2012.06.002 10.1099/0022-1317-68-5-1391 10.1371/journal.pone.0084531 10.1016/j.molcel.2021.08.011 10.1016/j.saa.2014.05.096 10.1101/cshperspect.a023747 10.1074/jbc.274.30.20763 10.1074/jbc.272.10.6324 10.1073/pnas.95.23.13363 |
ContentType | Journal Article |
Copyright | 2022 Elsevier B.V. Copyright © 2022 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier B.V. – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.bbagen.2022.130094 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
ExternalDocumentID | 35065183 10_1016_j_bbagen_2022_130094 S0304416522000125 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
ID | FETCH-LOGICAL-c395t-99dfb15e21d972edba456fdd44d0b6c9ca4589e567597192bfb3d50958791cd43 |
IEDL.DBID | .~1 |
ISSN | 0304-4165 1872-8006 |
IngestDate | Fri Jul 11 07:55:43 EDT 2025 Fri Jul 11 00:43:50 EDT 2025 Thu Apr 03 07:08:21 EDT 2025 Tue Jul 01 00:22:16 EDT 2025 Thu Apr 24 23:00:34 EDT 2025 Fri Feb 23 02:41:52 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | F_unbound PrPres PrPSc LP DMSO CNS SA Anti-prion PLS IC50 Curcumin Partial least squares Protein cross-linking PBS Acceptor SDS VDss IR MW Rot_Bond CNS_p PrP BBB_p PrPC Donor Prion PK N2a ATR |
Language | English |
License | Copyright © 2022 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c395t-99dfb15e21d972edba456fdd44d0b6c9ca4589e567597192bfb3d50958791cd43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 35065183 |
PQID | 2622279865 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_2636557547 proquest_miscellaneous_2622279865 pubmed_primary_35065183 crossref_primary_10_1016_j_bbagen_2022_130094 crossref_citationtrail_10_1016_j_bbagen_2022_130094 elsevier_sciencedirect_doi_10_1016_j_bbagen_2022_130094 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2022 2022-04-00 20220401 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: April 2022 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
PublicationYear | 2022 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Prusiner, Groth, Bolton, Kent, Hood (bb0175) 1984; 38 Ishibashi, Homma, Nakagaki, Fuse, Sano, Takatsuki (bb0080) 2015; 10 Lafon, Imberdis, Wang (bb0105) 2018; 8 Caughey, Raymond, Raymond, Maxson, Silveira, Baron (bb0020) 2003; 77 Ritz, Baty, Streibig, Gerhard (bb0190) 2015; 10 Hair, Sarstedt, Hopkins, Kuppelwieser (bb0045) 2014; 26 Kawasaki, Kawagoe, Chen, Teruya, Sakasegawa, Doh-ura (bb0085) 2007; 81 Giles, Olson, Prusiner (bb0055) 2017 Urano, Takahachi, Higashiura, Fujiwara, Funamoto, Imai (bb0235) 2020; 9 Manolova, Deneva, Antonov, Drakalska, Momekova, Lambov (bb0120) 2014; 132 Prusiner (bb0170) 1998; 95 Olmsted, Carlson, Klebe, Ruddle, Rosenbaum (bb0145) 1970; 65 Nishizawa, Teruya, Oguma, Sakasegawa, Schätzl, Gilch (bb0140) 2019; 108 Baron, Hughson, Raymond, Offerdahl, Barton, Raymond (bb0010) 2011; 50 Hotsumi, Tajiri, Nikaido, Sato, Makabe, Konno (bb0070) 2019; 29 Naslavsky, Stein, Yanai, Friedlander, Taraboulos (bb0130) 1997; 272 Ayrolles-Torro, Imberdis, Torrent, Toupet, Baskakov, Poncet-Montange (bb0005) 2011; 31 Nishida, Harris, Vilette, Laude, Frobert, Grassi (bb0135) 2000; 74 Teruya, Nishizawa, Doh-ura (bb0215) 2010; 29 Kimura, Nishizawa, Oguma, Nishimura, Sakasegawa, Teruya (bb0090) 2015 R Core Team. R (bb0180) 2020 Stahl, Borchelt, Hsiao, Prusiner (bb0205) 1987; 51 Endo, Nikaido, Nakadate, Ise, Konno (bb0040) 2014; 24 Schneider, Rasband, Eliceiri (bb0195) 2012; 9 Chasseigneaux, Pastore, Britton-Davidian, Manié, Stern, Callebert (bb0025) 2008; 153 Wang, Boysen, Wood, Kansiz, McNaughton, Hearn (bb0240) 2008; 89 Cheng (bb0030) 2001; 46 Race, Fadness, Chesebro (bb0185) 1987; 68 Peng, Lai (bb0155) 2012; 30 Ortiz, Pastor, Palomer, Cruciani, Gago, Wade (bb0150) 1997; 40 Shaked, Fridlander, Meiner, Taraboulos, Gabizon (bb0200) 1999; 274 Doh-ura, Perryman, Race, Chesebro (bb0035) 1995; 18 Li, Browning, Mahal, Oelschlegel, Weissmann (bb0110) 2010; 327 Weissmann, Li, Mahal, Browning (bb0250) 2011; 12 Bosque, Prusiner (bb0015) 2000; 74 Imberdis, Ayrolles-Torro, Duarte Rodrigues, Torrent, Alvarez-Martinez, Kovacs (bb0075) 2016; 11 Konno, Endo, Ise, Miyazaki, Aoki, Sanjoh (bb0095) 2014; 24 Teruya, Doh-ura (bb0210) 2016 Ferreira, Marques, Conceição, Macedo, Machado, Mascarello (bb0050) 2014; 9 Hewlings, Kalman (bb0065) 2017; 6 Teruya, Nishizawa, Oguma, Sakasegawa, Kitamoto, Doh-ura (bb0220) 2019; 1863 Prabaningdyah, Riyanto, Rohman (bb0165) 2018; 8 Pires, Blundell, Ascher (bb0160) 2015; 58 Naslavsky, Shmeeda, Friedlander, Yanai, Futerman, Barenholz (bb0125) 1999; 274 Hamanaka, Sakasegawa, Ohmoto, Kimura, Ando, Doh-ura (bb0060) 2011; 405 Zanusso, Fiorini, Ferrari, Meade-White, Barbieri, Brocchi (bb0255) 2014; 289 Mahal, Baker, Demczyk, Smith, Julius, Weissmann (bb0115) 2007; 104 Teruya, Wakao, Sato, Hamanaka, Nishizawa, Funayama (bb0225) 2015; 460 Kraus, Hoyt, Schwartz (bb0100) 2021; 81 Wei, Simko, Levy, Xie, Jin, Zemla (bb0245) 2013; vol. 230 Li (10.1016/j.bbagen.2022.130094_bb0110) 2010; 327 Ayrolles-Torro (10.1016/j.bbagen.2022.130094_bb0005) 2011; 31 Ishibashi (10.1016/j.bbagen.2022.130094_bb0080) 2015; 10 Kraus (10.1016/j.bbagen.2022.130094_bb0100) 2021; 81 Nishida (10.1016/j.bbagen.2022.130094_bb0135) 2000; 74 Bosque (10.1016/j.bbagen.2022.130094_bb0015) 2000; 74 Lafon (10.1016/j.bbagen.2022.130094_bb0105) 2018; 8 Cheng (10.1016/j.bbagen.2022.130094_bb0030) 2001; 46 Ortiz (10.1016/j.bbagen.2022.130094_bb0150) 1997; 40 Hamanaka (10.1016/j.bbagen.2022.130094_bb0060) 2011; 405 Giles (10.1016/j.bbagen.2022.130094_bb0055) 2017 Naslavsky (10.1016/j.bbagen.2022.130094_bb0130) 1997; 272 Teruya (10.1016/j.bbagen.2022.130094_bb0210) 2016 Pires (10.1016/j.bbagen.2022.130094_bb0160) 2015; 58 Ferreira (10.1016/j.bbagen.2022.130094_bb0050) 2014; 9 Prabaningdyah (10.1016/j.bbagen.2022.130094_bb0165) 2018; 8 Chasseigneaux (10.1016/j.bbagen.2022.130094_bb0025) 2008; 153 Schneider (10.1016/j.bbagen.2022.130094_bb0195) 2012; 9 Ritz (10.1016/j.bbagen.2022.130094_bb0190) 2015; 10 Race (10.1016/j.bbagen.2022.130094_bb0185) 1987; 68 Stahl (10.1016/j.bbagen.2022.130094_bb0205) 1987; 51 Kawasaki (10.1016/j.bbagen.2022.130094_bb0085) 2007; 81 Teruya (10.1016/j.bbagen.2022.130094_bb0215) 2010; 29 Teruya (10.1016/j.bbagen.2022.130094_bb0220) 2019; 1863 Wang (10.1016/j.bbagen.2022.130094_bb0240) 2008; 89 Zanusso (10.1016/j.bbagen.2022.130094_bb0255) 2014; 289 Hewlings (10.1016/j.bbagen.2022.130094_bb0065) 2017; 6 R Core Team. R (10.1016/j.bbagen.2022.130094_bb0180) Kimura (10.1016/j.bbagen.2022.130094_bb0090) 2015 Doh-ura (10.1016/j.bbagen.2022.130094_bb0035) 1995; 18 Mahal (10.1016/j.bbagen.2022.130094_bb0115) 2007; 104 Konno (10.1016/j.bbagen.2022.130094_bb0095) 2014; 24 Manolova (10.1016/j.bbagen.2022.130094_bb0120) 2014; 132 Endo (10.1016/j.bbagen.2022.130094_bb0040) 2014; 24 Naslavsky (10.1016/j.bbagen.2022.130094_bb0125) 1999; 274 Prusiner (10.1016/j.bbagen.2022.130094_bb0170) 1998; 95 Caughey (10.1016/j.bbagen.2022.130094_bb0020) 2003; 77 Urano (10.1016/j.bbagen.2022.130094_bb0235) 2020; 9 Shaked (10.1016/j.bbagen.2022.130094_bb0200) 1999; 274 Nishizawa (10.1016/j.bbagen.2022.130094_bb0140) 2019; 108 Weissmann (10.1016/j.bbagen.2022.130094_bb0250) 2011; 12 Baron (10.1016/j.bbagen.2022.130094_bb0010) 2011; 50 Prusiner (10.1016/j.bbagen.2022.130094_bb0175) 1984; 38 Teruya (10.1016/j.bbagen.2022.130094_bb0225) 2015; 460 Olmsted (10.1016/j.bbagen.2022.130094_bb0145) 1970; 65 Imberdis (10.1016/j.bbagen.2022.130094_bb0075) 2016; 11 Hotsumi (10.1016/j.bbagen.2022.130094_bb0070) 2019; 29 Wei (10.1016/j.bbagen.2022.130094_bb0245) 2013; vol. 230 Peng (10.1016/j.bbagen.2022.130094_bb0155) 2012; 30 Hair (10.1016/j.bbagen.2022.130094_bb0045) 2014; 26 |
References_xml | – volume: 74 start-page: 4377 year: 2000 end-page: 4386 ident: bb0015 article-title: Cultured Cell Sublines Highly Susceptible to Prion Infection publication-title: J. Virol. – volume: 24 start-page: 5621 year: 2014 end-page: 5626 ident: bb0040 article-title: Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor publication-title: Bioorg. Med. Chem. Lett. – volume: 30 start-page: 467 year: 2012 end-page: 480 ident: bb0155 article-title: Using partial least squares in operations management research: a practical guideline and summary of past research publication-title: J. Oper. Manag. – volume: 405 start-page: 285 year: 2011 end-page: 290 ident: bb0060 article-title: Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals publication-title: Biochem. Biophys. Res. Commun. – volume: 26 start-page: 106 year: 2014 end-page: 121 ident: bb0045 article-title: Partial least squares structural equation modeling (PLS-SEM): An emerging tool in business research publication-title: Eur. Bus. Rev. – volume: 274 start-page: 20763 year: 1999 end-page: 20771 ident: bb0125 article-title: Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions publication-title: J. Biol. Chem. – volume: 50 start-page: 4479 year: 2011 end-page: 4490 ident: bb0010 article-title: Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra publication-title: Biochemistry – volume: 12 start-page: 1109 year: 2011 end-page: 1117 ident: bb0250 article-title: Prions on the move publication-title: EMBO Rep. – volume: 10 year: 2015 ident: bb0080 article-title: Strain-dependent effect of macroautophagy on abnormally folded prion protein degradation in infected neuronal cells publication-title: PLoS One – volume: 8 start-page: 8023 year: 2018 ident: bb0105 article-title: Low doses of bioherbicide favour prion aggregation and propagation in vivo publication-title: Sci. Rep. – year: 2020 ident: bb0180 article-title: A Language and Environment for Statistical Computing – volume: 40 start-page: 1136 year: 1997 end-page: 1148 ident: bb0150 article-title: Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors publication-title: J. Med. Chem. – volume: 46 start-page: 61 year: 2001 end-page: 71 ident: bb0030 article-title: The power issue: determination of KB or Ki from IC50: a closer look at the Cheng–Prusoff equation, the Schild plot and related power equations publication-title: J. Pharmacol. Toxicol. Methods – volume: 51 start-page: 229 year: 1987 end-page: 240 ident: bb0205 article-title: Scrapie prion protein contains a phosphatidylinositol glycolipid publication-title: Cell. – volume: 29 start-page: 2157 year: 2019 end-page: 2161 ident: bb0070 article-title: Design, synthesis, and evaluation of a water soluble C5-monoketone type curcumin analogue as a potent amyloid β aggregation inhibitor publication-title: Bioorg. Med. Chem. Lett. – volume: 81 start-page: 4540 year: 2021 end-page: 4551.e6 ident: bb0100 article-title: High-resolution structure and strain comparison of infectious mammalian prions publication-title: Mol. Cell – volume: 9 start-page: 349 year: 2020 ident: bb0235 article-title: Curcumin derivative GT863 inhibits amyloid-beta production via inhibition of protein N-glycosylation publication-title: Cells. – volume: 108 start-page: 2814 year: 2019 end-page: 2820 ident: bb0140 article-title: Preparation and characterization of cellulose ether liposomes for the inhibition of prion formation in prion-infected cells publication-title: J. Pharm. Sci. – volume: 327 start-page: 869 year: 2010 end-page: 872 ident: bb0110 article-title: Darwinian evolution of prions in cell culture publication-title: Science – volume: 58 start-page: 4066 year: 2015 end-page: 4072 ident: bb0160 article-title: pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures publication-title: J. Med. Chem. – volume: 10 year: 2015 ident: bb0190 article-title: Dose-response analysis using R publication-title: PLoS One – volume: 289 start-page: 4870 year: 2014 end-page: 4881 ident: bb0255 article-title: Gerstmann-sträussler-scheinker disease and “anchorless prion protein” mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease publication-title: J. Biol. Chem. – volume: 104 start-page: 20908 year: 2007 end-page: 20913 ident: bb0115 article-title: Prion strain discrimination in cell culture: the cell panel assay publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 81 start-page: 12889 year: 2007 end-page: 12898 ident: bb0085 article-title: Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner publication-title: J. Virol. – volume: 74 start-page: 320 year: 2000 end-page: 325 ident: bb0135 article-title: Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein publication-title: J. Virol. – volume: 153 start-page: 1693 year: 2008 end-page: 1702 ident: bb0025 article-title: Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines publication-title: Arch. Virol. – volume: 18 start-page: 1 year: 1995 end-page: 9 ident: bb0035 article-title: Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells publication-title: Microb. Pathog. – volume: 38 start-page: 127 year: 1984 end-page: 134 ident: bb0175 article-title: Purification and structural studies of a major scrapie prion protein publication-title: Cell. – year: 2017 ident: bb0055 article-title: Developing therapeutics for PrP prion diseases publication-title: Cold Spring Harb. Perspect. Med. – volume: 9 start-page: 671 year: 2012 end-page: 675 ident: bb0195 article-title: NIH Image to ImageJ: 25 years of image analysis publication-title: Nat. Methods – volume: vol. 230 start-page: 11 year: 2013 ident: bb0245 article-title: corrplot: Visualization of a Correlation Matrix – volume: 9 year: 2014 ident: bb0050 article-title: Anti-prion activity of a panel of aromatic chemical compounds: in vitro in silico approaches publication-title: PLoS One – volume: 272 start-page: 6324 year: 1997 end-page: 6331 ident: bb0130 article-title: Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform * publication-title: J. Biol. Chem. – volume: 65 start-page: 129 year: 1970 end-page: 136 ident: bb0145 article-title: Isolation of microtubule protein from cultured mouse neuroblastoma cells publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 8 start-page: 172 year: 2018 end-page: 179 ident: bb0165 article-title: Application of FTIR spectroscopy and multivariate calibration for analysis of curcuminoid in syrup formulation publication-title: J. Appl. Pharm. Sci. – volume: 31 start-page: 14882 year: 2011 end-page: 14892 ident: bb0005 article-title: Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity publication-title: J. Neurosci. – volume: 132 start-page: 815 year: 2014 end-page: 820 ident: bb0120 article-title: The effect of the water on the curcumin tautomerism: A quantitative approach publication-title: Spectrochim. Acta A Mol. Biomol. Spectrosc. – volume: 68 start-page: 1391 year: 1987 end-page: 1399 ident: bb0185 article-title: Characterization of scrapie infection in mouse neuroblastoma cells publication-title: J. Gen. Virol. – volume: 460 start-page: 989 year: 2015 end-page: 995 ident: bb0225 article-title: Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells publication-title: Biochem. Biophys. Res. Commun. – volume: 6 year: 2017 ident: bb0065 article-title: Curcumin: a review of its’ effects on human health publication-title: Foods – volume: 95 start-page: 13363 year: 1998 end-page: 13383 ident: bb0170 article-title: Prions publication-title: PNAS – volume: 24 start-page: 685 year: 2014 end-page: 690 ident: bb0095 article-title: Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1 publication-title: Bioorg. Med. Chem. Lett. – volume: 89 start-page: 895 year: 2008 end-page: 905 ident: bb0240 article-title: Determination of the secondary structure of proteins in different environments by FTIR-ATR spectroscopy and PLS regression publication-title: Biopolymers. – year: 2015 ident: bb0090 article-title: Secretin receptor involvement in prion-infected cells and animals publication-title: FEBS Lett. – volume: 1863 start-page: 384 year: 2019 end-page: 394 ident: bb0220 article-title: Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction publication-title: Biochim. Biophys. Acta Gen. Subj. – volume: 11 year: 2016 ident: bb0075 article-title: A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases publication-title: Mol. Neurodegener. – year: 2016 ident: bb0210 article-title: Insights from Therapeutic Studies for PrP Prion Disease publication-title: Cold Spring Harb. Perspect. Med. – volume: 274 start-page: 17981 year: 1999 end-page: 17986 ident: bb0200 article-title: Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity publication-title: J. Biol. Chem. – volume: 77 start-page: 5499 year: 2003 end-page: 5502 ident: bb0020 article-title: Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin publication-title: J. Virol. – volume: 29 start-page: 493 year: 2010 end-page: 500 ident: bb0215 article-title: Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells publication-title: Protein J. – volume: 104 start-page: 20908 year: 2007 ident: 10.1016/j.bbagen.2022.130094_bb0115 article-title: Prion strain discrimination in cell culture: the cell panel assay publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0710054104 – volume: vol. 230 start-page: 11 year: 2013 ident: 10.1016/j.bbagen.2022.130094_bb0245 – volume: 10 year: 2015 ident: 10.1016/j.bbagen.2022.130094_bb0190 article-title: Dose-response analysis using R publication-title: PLoS One doi: 10.1371/journal.pone.0146021 – volume: 18 start-page: 1 year: 1995 ident: 10.1016/j.bbagen.2022.130094_bb0035 article-title: Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells publication-title: Microb. Pathog. doi: 10.1016/S0882-4010(05)80008-7 – volume: 9 start-page: 671 year: 2012 ident: 10.1016/j.bbagen.2022.130094_bb0195 article-title: NIH Image to ImageJ: 25 years of image analysis publication-title: Nat. Methods doi: 10.1038/nmeth.2089 – volume: 26 start-page: 106 year: 2014 ident: 10.1016/j.bbagen.2022.130094_bb0045 article-title: Partial least squares structural equation modeling (PLS-SEM): An emerging tool in business research publication-title: Eur. Bus. Rev. doi: 10.1108/EBR-10-2013-0128 – volume: 89 start-page: 895 year: 2008 ident: 10.1016/j.bbagen.2022.130094_bb0240 article-title: Determination of the secondary structure of proteins in different environments by FTIR-ATR spectroscopy and PLS regression publication-title: Biopolymers. doi: 10.1002/bip.21022 – volume: 77 start-page: 5499 year: 2003 ident: 10.1016/j.bbagen.2022.130094_bb0020 article-title: Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin publication-title: J. Virol. doi: 10.1128/JVI.77.9.5499-5502.2003 – volume: 74 start-page: 4377 year: 2000 ident: 10.1016/j.bbagen.2022.130094_bb0015 article-title: Cultured Cell Sublines Highly Susceptible to Prion Infection publication-title: J. Virol. doi: 10.1128/JVI.74.9.4377-4386.2000 – volume: 289 start-page: 4870 year: 2014 ident: 10.1016/j.bbagen.2022.130094_bb0255 article-title: Gerstmann-sträussler-scheinker disease and “anchorless prion protein” mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.531335 – volume: 29 start-page: 493 year: 2010 ident: 10.1016/j.bbagen.2022.130094_bb0215 article-title: Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells publication-title: Protein J. doi: 10.1007/s10930-010-9278-9 – volume: 11 year: 2016 ident: 10.1016/j.bbagen.2022.130094_bb0075 article-title: A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases publication-title: Mol. Neurodegener. doi: 10.1186/s13024-016-0074-7 – volume: 153 start-page: 1693 year: 2008 ident: 10.1016/j.bbagen.2022.130094_bb0025 article-title: Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines publication-title: Arch. Virol. doi: 10.1007/s00705-008-0177-8 – volume: 274 start-page: 17981 year: 1999 ident: 10.1016/j.bbagen.2022.130094_bb0200 article-title: Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.25.17981 – volume: 8 start-page: 8023 year: 2018 ident: 10.1016/j.bbagen.2022.130094_bb0105 article-title: Low doses of bioherbicide favour prion aggregation and propagation in vivo publication-title: Sci. Rep. doi: 10.1038/s41598-018-25966-9 – volume: 31 start-page: 14882 year: 2011 ident: 10.1016/j.bbagen.2022.130094_bb0005 article-title: Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0547-11.2011 – volume: 65 start-page: 129 year: 1970 ident: 10.1016/j.bbagen.2022.130094_bb0145 article-title: Isolation of microtubule protein from cultured mouse neuroblastoma cells publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.65.1.129 – volume: 40 start-page: 1136 year: 1997 ident: 10.1016/j.bbagen.2022.130094_bb0150 article-title: Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors publication-title: J. Med. Chem. doi: 10.1021/jm9601617 – volume: 46 start-page: 61 year: 2001 ident: 10.1016/j.bbagen.2022.130094_bb0030 article-title: The power issue: determination of KB or Ki from IC50: a closer look at the Cheng–Prusoff equation, the Schild plot and related power equations publication-title: J. Pharmacol. Toxicol. Methods doi: 10.1016/S1056-8719(02)00166-1 – year: 2015 ident: 10.1016/j.bbagen.2022.130094_bb0090 article-title: Secretin receptor involvement in prion-infected cells and animals publication-title: FEBS Lett. doi: 10.1016/j.febslet.2015.05.039 – volume: 74 start-page: 320 year: 2000 ident: 10.1016/j.bbagen.2022.130094_bb0135 article-title: Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein publication-title: J. Virol. doi: 10.1128/JVI.74.1.320-325.2000 – volume: 24 start-page: 685 year: 2014 ident: 10.1016/j.bbagen.2022.130094_bb0095 article-title: Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2013.11.039 – volume: 10 year: 2015 ident: 10.1016/j.bbagen.2022.130094_bb0080 article-title: Strain-dependent effect of macroautophagy on abnormally folded prion protein degradation in infected neuronal cells publication-title: PLoS One doi: 10.1371/journal.pone.0137958 – volume: 1863 start-page: 384 year: 2019 ident: 10.1016/j.bbagen.2022.130094_bb0220 article-title: Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction publication-title: Biochim. Biophys. Acta Gen. Subj. doi: 10.1016/j.bbagen.2018.11.008 – volume: 24 start-page: 5621 year: 2014 ident: 10.1016/j.bbagen.2022.130094_bb0040 article-title: Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2014.10.076 – volume: 38 start-page: 127 year: 1984 ident: 10.1016/j.bbagen.2022.130094_bb0175 article-title: Purification and structural studies of a major scrapie prion protein publication-title: Cell. doi: 10.1016/0092-8674(84)90533-6 – volume: 58 start-page: 4066 year: 2015 ident: 10.1016/j.bbagen.2022.130094_bb0160 article-title: pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00104 – volume: 8 start-page: 172 year: 2018 ident: 10.1016/j.bbagen.2022.130094_bb0165 article-title: Application of FTIR spectroscopy and multivariate calibration for analysis of curcuminoid in syrup formulation publication-title: J. Appl. Pharm. Sci. – volume: 50 start-page: 4479 year: 2011 ident: 10.1016/j.bbagen.2022.130094_bb0010 article-title: Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra publication-title: Biochemistry doi: 10.1021/bi2003907 – volume: 81 start-page: 12889 year: 2007 ident: 10.1016/j.bbagen.2022.130094_bb0085 article-title: Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner publication-title: J. Virol. doi: 10.1128/JVI.01563-07 – volume: 327 start-page: 869 year: 2010 ident: 10.1016/j.bbagen.2022.130094_bb0110 article-title: Darwinian evolution of prions in cell culture publication-title: Science doi: 10.1126/science.1183218 – volume: 405 start-page: 285 year: 2011 ident: 10.1016/j.bbagen.2022.130094_bb0060 article-title: Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.01.030 – volume: 12 start-page: 1109 year: 2011 ident: 10.1016/j.bbagen.2022.130094_bb0250 article-title: Prions on the move publication-title: EMBO Rep. doi: 10.1038/embor.2011.192 – volume: 6 year: 2017 ident: 10.1016/j.bbagen.2022.130094_bb0065 article-title: Curcumin: a review of its’ effects on human health publication-title: Foods doi: 10.3390/foods6100092 – volume: 460 start-page: 989 year: 2015 ident: 10.1016/j.bbagen.2022.130094_bb0225 article-title: Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.03.139 – volume: 29 start-page: 2157 year: 2019 ident: 10.1016/j.bbagen.2022.130094_bb0070 article-title: Design, synthesis, and evaluation of a water soluble C5-monoketone type curcumin analogue as a potent amyloid β aggregation inhibitor publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2019.06.052 – year: 2016 ident: 10.1016/j.bbagen.2022.130094_bb0210 article-title: Insights from Therapeutic Studies for PrP Prion Disease publication-title: Cold Spring Harb. Perspect. Med. – volume: 51 start-page: 229 year: 1987 ident: 10.1016/j.bbagen.2022.130094_bb0205 article-title: Scrapie prion protein contains a phosphatidylinositol glycolipid publication-title: Cell. doi: 10.1016/0092-8674(87)90150-4 – volume: 108 start-page: 2814 year: 2019 ident: 10.1016/j.bbagen.2022.130094_bb0140 article-title: Preparation and characterization of cellulose ether liposomes for the inhibition of prion formation in prion-infected cells publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2019.03.025 – volume: 9 start-page: 349 year: 2020 ident: 10.1016/j.bbagen.2022.130094_bb0235 article-title: Curcumin derivative GT863 inhibits amyloid-beta production via inhibition of protein N-glycosylation publication-title: Cells. doi: 10.3390/cells9020349 – volume: 30 start-page: 467 year: 2012 ident: 10.1016/j.bbagen.2022.130094_bb0155 article-title: Using partial least squares in operations management research: a practical guideline and summary of past research publication-title: J. Oper. Manag. doi: 10.1016/j.jom.2012.06.002 – volume: 68 start-page: 1391 year: 1987 ident: 10.1016/j.bbagen.2022.130094_bb0185 article-title: Characterization of scrapie infection in mouse neuroblastoma cells publication-title: J. Gen. Virol. doi: 10.1099/0022-1317-68-5-1391 – volume: 9 year: 2014 ident: 10.1016/j.bbagen.2022.130094_bb0050 article-title: Anti-prion activity of a panel of aromatic chemical compounds: in vitro in silico approaches publication-title: PLoS One doi: 10.1371/journal.pone.0084531 – ident: 10.1016/j.bbagen.2022.130094_bb0180 – volume: 81 start-page: 4540 issue: 21 year: 2021 ident: 10.1016/j.bbagen.2022.130094_bb0100 article-title: High-resolution structure and strain comparison of infectious mammalian prions publication-title: Mol. Cell doi: 10.1016/j.molcel.2021.08.011 – volume: 132 start-page: 815 year: 2014 ident: 10.1016/j.bbagen.2022.130094_bb0120 article-title: The effect of the water on the curcumin tautomerism: A quantitative approach publication-title: Spectrochim. Acta A Mol. Biomol. Spectrosc. doi: 10.1016/j.saa.2014.05.096 – year: 2017 ident: 10.1016/j.bbagen.2022.130094_bb0055 article-title: Developing therapeutics for PrP prion diseases publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a023747 – volume: 274 start-page: 20763 year: 1999 ident: 10.1016/j.bbagen.2022.130094_bb0125 article-title: Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.30.20763 – volume: 272 start-page: 6324 year: 1997 ident: 10.1016/j.bbagen.2022.130094_bb0130 article-title: Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform * publication-title: J. Biol. Chem. doi: 10.1074/jbc.272.10.6324 – volume: 95 start-page: 13363 year: 1998 ident: 10.1016/j.bbagen.2022.130094_bb0170 article-title: Prions publication-title: PNAS doi: 10.1073/pnas.95.23.13363 |
SSID | ssj0000595 |
Score | 2.3903499 |
Snippet | Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with... Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrP ). In this study, two types of cells persistently infected with... Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSᶜ). In this study, two types of cells persistently infected with... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 130094 |
SubjectTerms | Anti-prion Cell Line chemometrics Curcumin Curcumin - pharmacology dose response hydrogen hydrophobicity Partial least squares Prion Prion Proteins prions Prions - chemistry Prions - metabolism Protein cross-linking PrPSc Proteins - metabolism |
Title | Activities of curcumin-related compounds in two cell lines persistently infected with different prion strains |
URI | https://dx.doi.org/10.1016/j.bbagen.2022.130094 https://www.ncbi.nlm.nih.gov/pubmed/35065183 https://www.proquest.com/docview/2622279865 https://www.proquest.com/docview/2636557547 |
Volume | 1866 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEB_EIu1LabUf11aJ4Gs8d5Psbh6Po3JV9MUKvoXLx8IV3Ttu9yi-9G_vTLJr8cEKPmZJYJiZzPySnckP4CiTmQuZ8rjTrOay9oFXNhdcUD5AvCHmlpqTLy6L2bU8u1E3WzAdemGorLKP_Smmx2jdfxn32hyvFovxFf3UQziBACJep1CjuZQlefnxn39lHggfVPqTIDnNHtrnYo2Xtbhp6RXUPI-0yFo-lZ6egp8xDZ2-g7c9fmSTJOJ72ArNLuwkRsn7XXg9HQjc9uBu4iI1BJ6F2bJmbrN2m7tFw2P7SvCMqsmJVKlli4Z1v5eMLvEZwc6WregaDR2g6W7vWSrYwhV0acsGSpWOrdZoVNZGlon2A1yffv85nfGeXYE7oVXHtfa1zVTIM6_LPHg7RyxVey-lP7GF0w7HlQ4KTxS6RBxoays8wgtVlTpzXoqPsN0sm_AZGIYFTLXeuaISsqIzlLY2O8EEaXUIVo5ADEo1rn96nGS7NUON2S-TTGHIFCaZYgT8YdUqPb3xzPxysJd55EIGs8MzKw8H8xq0EWl73oTlpjV5Qb3CuirU_-aIQiHqleUIPiXfeJBXKIR4qJ4vL5btK7yhUSoW-gbb3XoT9hEHdfYgOvoBvJr8OJ9d_gXb4AeI |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7ShJJeSpO-to9EgVzVjS3Jto5hadjmdWkCuYnVw7Al8S5rLyWX_vbOSHZKD2mgR9sSDDOjmU_yjD6Aw0xmLmTK40qzmsvaB17ZXHBB-QDxhphZak6-uCym1_L0Rt1swGTohaGyyj72p5geo3X_Ztxrc7ycz8ff6acewgkEEPE4RT2DLYnLl2gMvvz6U-eB-EGlXwmS0_Chfy4WeVmLq5auQc3zyIus5WP56TH8GfPQySt42QNIdpxk3IGN0OzC80Qpeb8L25OBwe013B27yA2Bm2G2qJlbr9z6bt7w2L8SPKNycmJVatm8Yd3PBaNTfEa4s2VLOkdDD2i623uWKrZwBp3asoFTpWPLFVqVtZFmon0D1ydfryZT3tMrcCe06rjWvraZCnnmdZkHb2cIpmrvpfRHtnDa4XOlg8IthS4RCNraCo_4QlWlzpyX4i1sNosmvAeGcQFzrXeuqISsaBOlrc2OMENaHYKVIxCDUo3r7x4n2W7NUGT2wyRTGDKFSaYYAX-YtUx3bzwxvhzsZf7yIYPp4YmZB4N5DdqItD1rwmLdmrygZmFdFepfY0ShEPbKcgTvkm88yCsUYjxUz4f_lm0ftqdXF-fm_Nvl2Ud4QV9S5dAn2OxW6_AZQVFn96LT_wbIlAkW |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activities+of+curcumin-related+compounds+in+two+cell+lines+persistently+infected+with+different+prion+strains&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Teruya%2C+Kenta&rft.au=Iwabuchi%2C+Sara&rft.au=Watanabe%2C+Yuki&rft.au=Tsuchida%2C+Rikiya&rft.date=2022-04-01&rft.issn=0304-4165&rft.volume=1866&rft.issue=4&rft.spage=130094&rft_id=info:doi/10.1016%2Fj.bbagen.2022.130094&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbagen_2022_130094 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |